Elekta

Board/Management Information • Dec 1, 2008

ELEKTA'S ELECTION COMMITTEE

Press Release

Stockholm, Sweden, December 1, 2008

In accordance with the decision at the Annual General Meeting on September 18, 2008, Elekta's Chairman of the Board has contacted the company's largest shareholders to form an Election Committee. Subsequently, the shareholders agreeing to participate in the work of the Election Committee has each nominated a representative.

The Election Committee, that will prepare matters prior to the Annual General Meeting 2009 consists of Ole E. Dahl, Orkla ASA, Åsa Nisell, Swedbank Robur funds, Martin Jonasson, Second National AP fund, Laurent Leksell, representing his private and companies' holdings, and Akbar Seddigh, Chairman of the Board. The Election Committee will appoint one of the members as Chairman.

Combined, the shareholders in the Election Committee represented over 42 percent of the votes in Elekta AB on October 31, 2008.

Shareholders wishing to submit proposals to Elekta's Election Committee can do so by e-mail at valberedningen@elekta.com or by letter to: Elekta AB, Election Committee, Box 7593, SE-103 93 Stockholm, Sweden.

The Committee's assignment remains effective until a new Election Committee is appointed.

******

For further information, please contact:

Lena Schattauer, Investor Relations, Elekta AB Tel: +46 8 587 257 22, +46 70 595 51 00, e-mail: lena.schattauer@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.